Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals reports 56.8% increase in revenue
Published in Lab Business Week, May 21st, 2006
Revenues in fiscal 2005 increased by $8,882,210, or 56.8%, to $24,527,379, versus revenues of $15,645,169 in fiscal 2004. Higher sales volumes for etimicin powder and transfusion products accounted for approximately $6.4 million of the additional revenues.
The company aggressively marketed a new transfusion product, "AIYI," which was first introduced in 2004. Etimicin was also added in 2005 to the National Essential Drugs List, which serves as a purchasing guide for the provinces. The 2004 financial results did not include...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-05-21)
More Articles from Lab Business Week
- Acadia Pharmaceuticals, Inc.
Acadia announces proposed public stock offering - Biomerica, Inc.
Biomerica reports diagnostics sales of almost $1M - Bradmer Pharmaceuticals, Inc.
Bradmer commences trading on Toronto Stock Exchange - China Biopharmaceuticals Holdings, Inc.
China Biopharmaceuticals Holdings records 280% increase in revenue - Dynavax Technologies Corporation
Dynavax to advance cancer, hepatitis B, and hepatitis C therapy with $50 million funding - Endo Pharmaceuticals Holdings Inc.
Endo Pharmaceuticals reports net sales of $205 million in first quarter - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
